K003503

Substantially Equivalent

N LATEX CYSTATIN C

Applicant: Dade Behring, Inc.
Product code: NDY
Advisory panel: Clinical Chemistry
Date received: 2000-11-13
Decision date: 2001-03-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: P.O. Box 6101, Newark, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.